Related Experiment Videos
Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients
H Z Zokufa1, K A Rodvold, R A Blum
1College of Pharmacy, University of Minnesota, Minneapolis.
Pharmacotherapy
|January 1, 1989
Summary
Simulating five vancomycin dosing methods revealed significant underprediction of drug clearance. None of the methods satisfactorily achieved target vancomycin peak and trough concentrations in patients.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Clinical Pharmacy
Background:
- Vancomycin dosing requires precise pharmacokinetic parameter estimation for optimal therapeutic outcomes.
- Existing dosing nomograms and simulation methods vary in their ability to predict effective vancomycin serum concentrations.
- Accurate prediction of vancomycin peak and trough levels is crucial for efficacy and minimizing toxicity.
Purpose of the Study:
- To evaluate and compare the accuracy of five different vancomycin dosing methods (Matzke, Moellering, Nielsen, Lake-Peterson, and manufacturer's) in achieving target peak and trough serum concentrations.
- To assess the performance of these methods in predicting systemic drug clearance.
- To identify the most suitable initial dosing strategy for vancomycin therapy.
Main Methods:
- Simulation of five vancomycin dosing regimens in 37 patients.
- Collection of ten serum samples post-infusion for pharmacokinetic analysis.
- Nonlinear iterative least squares regression and a two-compartment, open-infusion model to estimate pharmacokinetic values.
- Simulation of steady-state peak and trough concentrations using patient-specific pharmacokinetic values and each dosing method.
Main Results:
- All simulated dosing methods underpredicted actual vancomycin systemic clearance.
- The Nielsen method exhibited the lowest prediction of drug clearance, while the Matzke method recommended the highest dosage.
- Only 3-16% of patients achieved the recommended vancomycin peak and trough concentrations across all simulated methods.
- No single method demonstrated satisfactory performance in attaining desired vancomycin therapeutic ranges.
Conclusions:
- Current vancomycin dosing methods demonstrate limitations in accurately predicting pharmacokinetic parameters and achieving target serum concentrations.
- The simulated methods, including the manufacturer's recommendations, were inadequate for ensuring therapeutic vancomycin levels.
- The Lake-Peterson method is suggested as a potential initial approach, but requires close patient monitoring and dosage adjustments.